UB Paderborn / Katalog / Suche / in CDI

SAMANTHA: A European registry study to prospectively observe treatment patterns and outcomes in participants with HER2-positive unresectable locally advanced (LA) or metastatic breast cancer (mBC)

Annals of oncology, 2018-10, Vol.29, p.viii119-viii119

2018

Link zum Volltext

Verfügbarkeit prüfen

Diastolic transient inward current in long QT syndrome type 3 is caused by Ca2+ overload and inhibited by ranolazine

Journal of molecular and cellular cardiology, 2009-08, Vol.47 (2), p.326-334

2009

Link zum Volltext

Verfügbarkeit prüfen

308P Real-world outcomes among HER2+ metastatic breast cancer patients with brain metastases

Annals of oncology, 2020-09, Vol.31, p.S365-S366

2020

Link zum Volltext

Verfügbarkeit prüfen

169P Trastuzumab use among patients with HER2-positive metastatic breast cancer in an electronic health records database

Annals of oncology, 2020-05, Vol.31, p.S76-S77

2020

Link zum Volltext

Verfügbarkeit prüfen

Another calcium paradox in heart failure

Journal of molecular and cellular cardiology, 2008-07, Vol.45 (1), p.28-31

2008

Link zum Volltext

Verfügbarkeit prüfen

Use of trastuzumab emtansine (T-DM1; K) after pertuzumab + trastuzumab (PH) in patients with HER2-positive metastatic breast cancer (mBC): Challenges in assessing effectiveness of treatment sequencing in the real world (RW)

Annals of oncology, 2019-10, Vol.30, p.v129

2019

Link zum Volltext

Verfügbarkeit prüfen

356P - Use of trastuzumab emtansine (T-DM1; K) after pertuzumab + trastuzumab (PH) in patients with HER2-positive metastatic breast cancer (mBC): Challenges in assessing effectiveness of treatment sequencing in the real world (RW)

Annals of oncology, 2019-10, Vol.30, p.v129-v129

2019

Link zum Volltext

Verfügbarkeit prüfen

The nitrodibenzofuran chromophore: a new caging group for ultra-efficient photolysis in living cells

Nature methods, 2006-01, Vol.3 (1), p.35-40

2006

Link zum Volltext

Verfügbarkeit prüfen

Abstract P1-12-10: Safety and efficacy of trastuzumab emtansine (T-DM1) in 399 patients with central nervous system metastases: Exploratory subgroup analysis from the KAMILLA study

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P1-P1-12-10

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-21-04: Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent/metastatic breast cancer (PERUSE)

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P4-P4-21-04

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract P4-21-07: Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy in patients ≥65 years with HER2-positive locally recurrent/metastatic breast cancer: Subgroup analyses of the PERUSE study

Cancer research (Chicago, Ill.), 2017-02, Vol.77 (4_Supplement), p.P4-P4-21-07

2017

Link zum Volltext

Verfügbarkeit prüfen

The open-label, multinational, multicenter, Phase IIIB umbrella study of subcutaneous trastuzumab with or without chemotherapy or pertuzumab in patients (pts) with HER2-positive early breast cancer (EBC) or metastatic breast cancer (MBC): Pooled analysis of safety data from the UmbHER1 program

European journal of cancer (1990), 2018-04, Vol.92, p.S105-S106

2018

Link zum Volltext

Verfügbarkeit prüfen

370 (PB-165) - The open-label, multinational, multicenter, Phase IIIB umbrella study of subcutaneous trastuzumab with or without chemotherapy or pertuzumab in patients (pts) with HER2-positive early breast cancer (EBC) or metastatic breast cancer (MBC): Pooled analysis of safety data from the UmbHER1 program

European journal of cancer (1990), 2018-04, Vol.92, p.S105-S106

2018

Link zum Volltext

Verfügbarkeit prüfen

Paradoxical SR Ca2+ release in guinea‐pig cardiac myocytes after β‐adrenergic stimulation revealed by two‐photon photolysis of caged Ca2

The Journal of physiology, 2005-06, Vol.565 (3), p.801-813

2005

Link zum Volltext

Verfügbarkeit prüfen

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Annals of oncology, 2019-05, Vol.30 (5), p.766

2019

Link zum Volltext

Verfügbarkeit prüfen

Diastolic transient inward current in long QT syndrome type 3 is caused by Ca 2+ overload and inhibited by ranolazine

Journal of molecular and cellular cardiology, 2009, Vol.47 (2), p.326-334

2009

Link zum Volltext

Verfügbarkeit prüfen

356PUse of trastuzumab emtansine (T-DM1; K) after pertuzumab + trastuzumab (PH) in patients with HER2-positive metastatic breast cancer (mBC): Challenges in assessing effectiveness of treatment sequencing in the real world (RW)

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Link zum Volltext

Verfügbarkeit prüfen

365TiPSAMANTHA: A European registry study to prospectively observe treatment patterns and outcomes in participants with HER2-positive unresectable locally advanced (LA) or metastatic breast cancer (mBC)

Annals of oncology, 2018-10, Vol.29 (suppl_8)

2018

Link zum Volltext

Verfügbarkeit prüfen

Pharmacokinetics of the novel dual endothelin receptor antagonist macitentan in subjects with hepatic or renal impairment

Journal of clinical pharmacology, 2014-03, Vol.54 (3), p.291-300

2014

Link zum Volltext

Verfügbarkeit prüfen

Macitentan, a dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertension, does not affect cardiac repolarization in healthy subjects

Pulmonary pharmacology & therapeutics, 2014-10, Vol.29 (1), p.41-48

2014

Link zum Volltext

Verfügbarkeit prüfen

Rubidium Chloride Fuses Split Circadian Activity Rhythms in Hamsters Housed in Bright Constant Light

Chronobiology international, 1994, Vol.11 (2), p.65-71

1994

Link zum Volltext

Verfügbarkeit prüfen

Contribution a l'etude du gros rein polykystique et son operation

Lindegger, Gaspard

1896

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

SAMANTHA: A European registry study to prospectively observe treatment patterns and outcomes in participants with HER2-positive unresectable locally advanced (LA) or metastatic breast cancer (mBC)

Diastolic transient inward current in long QT syndrome type 3 is caused by Ca2+ overload and inhibited by ranolazine

308P Real-world outcomes among HER2+ metastatic breast cancer patients with brain metastases

169P Trastuzumab use among patients with HER2-positive metastatic breast cancer in an electronic health records database

Another calcium paradox in heart failure

Use of trastuzumab emtansine (T-DM1; K) after pertuzumab + trastuzumab (PH) in patients with HER2-positive metastatic breast cancer (mBC): Challenges in assessing effectiveness of treatment sequencing in the real world (RW)

356P - Use of trastuzumab emtansine (T-DM1; K) after pertuzumab + trastuzumab (PH) in patients with HER2-positive metastatic breast cancer (mBC): Challenges in assessing effectiveness of treatment sequencing in the real world (RW)

The nitrodibenzofuran chromophore: a new caging group for ultra-efficient photolysis in living cells

Abstract P1-12-10: Safety and efficacy of trastuzumab emtansine (T-DM1) in 399 patients with central nervous system metastases: Exploratory subgroup analysis from the KAMILLA study

Abstract P4-21-04: Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent/metastatic breast cancer (PERUSE)

Abstract P4-21-07: Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy in patients ≥65 years with HER2-positive locally recurrent/metastatic breast cancer: Subgroup analyses of the PERUSE study

The open-label, multinational, multicenter, Phase IIIB umbrella study of subcutaneous trastuzumab with or without chemotherapy or pertuzumab in patients (pts) with HER2-positive early breast cancer (EBC) or metastatic breast cancer (MBC): Pooled analysis of safety data from the UmbHER1 program

Paradoxical SR Ca2+ release in guinea‐pig cardiac myocytes after β‐adrenergic stimulation revealed by two‐photon photolysis of caged Ca2

Preliminary safety and efficacy of first-line pertuzumab combined with trastuzumab and taxane therapy for HER2-positive locally recurrent or metastatic breast cancer (PERUSE)

Diastolic transient inward current in long QT syndrome type 3 is caused by Ca 2+ overload and inhibited by ranolazine

356PUse of trastuzumab emtansine (T-DM1; K) after pertuzumab + trastuzumab (PH) in patients with HER2-positive metastatic breast cancer (mBC): Challenges in assessing effectiveness of treatment sequencing in the real world (RW)

365TiPSAMANTHA: A European registry study to prospectively observe treatment patterns and outcomes in participants with HER2-positive unresectable locally advanced (LA) or metastatic breast cancer (mBC)

Pharmacokinetics of the novel dual endothelin receptor antagonist macitentan in subjects with hepatic or renal impairment

Macitentan, a dual endothelin receptor antagonist for the treatment of pulmonary arterial hypertension, does not affect cardiac repolarization in healthy subjects

Rubidium Chloride Fuses Split Circadian Activity Rhythms in Hamsters Housed in Bright Constant Light

Contribution a l'etude du gros rein polykystique et son operation

Suchergebnisse filtern